Perovskite solar is approaching the commercialization window, but stability and mass-production yield remain key hurdles
AI summary card
Perovskite solar is approaching the commercialization window, but stability and mass-production yield remain key hurdles
Bernstein believes perovskites could become the next-generation solar technology through higher efficiency and potentially lower manufacturing costs, but verification of a truly bankable lifespan exceeding 20 years remains insufficient, making commercialization more likely around 2028.
- As a silicon-cell tandem material, perovskites can significantly improve efficiency; the report cites an approximately 30% efficiency uplift after tandem integration.
- The main obstacles are no longer proof of concept, but degradation caused by damp heat and light exposure, lead-leakage risk, the lack of a 20-year warranty track record, and uniformity and yield at scale.
- The most direct relevance is to FSLR: the Oxford PV license is viewed as a defensive move, and if perovskites progress along the 2028 timeline, FSLR could face a substitution threat.
- The relevance to TE is second-order: its US-based solar manufacturing and IRA/45X narrative is similar to that of Tandem PV, and it could potentially partner with perovskite developers in the future.
Report interpretation
Overview
This report focuses on perovskite solar technology within the Americas power and energy transition. Combining discussions with Tandem PV CEO Scott Wharton and Bernstein's proprietary research, it examines perovskites versus crystalline silicon and CdTe in terms of efficiency, cost, architecture, competitive landscape, commercialization opportunities, and risks, and provides coverage read-throughs for FSLR and TE.
Core views
The core view is that perovskites are an important candidate for next-generation solar technology, with advantages including high light-absorption efficiency, solution processing, and potentially low manufacturing costs; as a tandem material for silicon cells, they can achieve higher efficiency than today's mainstream modules. However, their soft ionic lattice also creates chemical vulnerabilities, with moisture, heat, light, and natural environments causing degradation of the crystal structure. Therefore, the key to commercialization is not short-term efficiency records, but proving more than 20 years of stable operation, achieving mass-production yields, and gaining project-finance acceptance. The report judges that commercialization is most likely around 2028.
Analysis framework
The report combines technology-route comparisons, analysis of the corporate competitive landscape, application-scenario breakdowns, and read-throughs to covered companies. At the technology level, it compares crystalline silicon, CdTe, and perovskites; at the industry level, it distinguishes 2T monolithic tandem and 4T mechanical tandem architectures; at the investment level, it maps perovskite progress to FSLR's CdTe route and TE's US solar manufacturing theme.
Methodology notes
Comparison of crystalline silicon, CdTe, and perovskite technologies
Crystalline silicon is a mature thick-wafer route, CdTe is a thin-film semiconductor with a fixed composition, and perovskites are a class of tunable thin-film absorber materials with an ABX3 structure; the report compares the three across efficiency, cost, reliability, and manufacturing pathways.
Two-terminal versus four-terminal tandem architecture
The 2T architecture deposits perovskites directly onto a silicon cell, offering simpler integration but concentrated yield risks; the 4T architecture keeps the perovskite and silicon cells electrically independent and can be paired with silicon routes such as TOPCon, HJT, PERC, or IBC.
Valuation methods for covered companies
FSLR is valued using SOTP, including a gross-profit multiple, tax-credit phase-down, discounted backlog, the TOPCon licensing option, and probability-weighted cash; TE is valued using a 2030 probability-weighted EBITDA scenario and an 8x multiple.
Asset mapping & comparison
Structured mapping from thesis to named assets (strengths, weaknesses, peers, risks).
- First Solar, Inc. (FSLR)Most directly covered read-through name
- Strengths
- Established CdTe thin-film route, internal R&D investment, the 2023 Evolar acquisition, a perovskite development line in Perrysburg, and a US patent license from Oxford PV.
- Weaknesses
- The Oxford PV license is interpreted by the report as a defensive move, potentially indicating that internal perovskite R&D has not yet reached the commercialization threshold; the license also explicitly excludes crystalline-silicon tandem architectures.
- Comparison
- If perovskites progress along the 2028 timeline, FSLR's CdTe route could face substitution pressure from higher-efficiency technologies.
- Risks
- Perovskite commercialization could create a substitution threat; adverse TOPCon litigation, capacity expansion or lower utilization, and import-tariff risks also represent downside risks.
- T1 Energy Inc. (TE)Second-order covered read-through name
- Strengths
- FEOC compliance, 45X eligibility, and a US solar manufacturing reshoring narrative similar to Tandem PV's US-based tandem manufacturing theme.
- Weaknesses
- There is currently no direct overlap with perovskite technology; the relevance is driven more by potential future partnerships than by existing technological advantages.
- Comparison
- Both TE and Tandem PV benefit from the US return of capital-intensive solar manufacturing supported by IRA/45X, but they are not direct competitors.
- Risks
- Dependence on policy support, manufacturing scale-up, and future partnership execution; current relevance remains indirect.
- Tandem PVPrivate perovskite company and report interview subject
- Strengths
- Uses a 4T architecture that is theoretically compatible with multiple silicon-cell routes; its Fremont demonstration manufacturing line opened in April 2026, targeting utility customers.
- Weaknesses
- Still requires third-party certification, full-size commercial-module validation, long-term stability data, and proof of scaled manufacturing yields.
- Comparison
- Compared with the 2T route, the 4T route sacrifices some integration simplicity but preserves flexibility on the silicon-side technology route.
- Risks
- Degradation, warranty coverage, lead toxicity, manufacturing uniformity, and customer bankability.
Key data
- Perovskite commercialization timingApproximately 2028The report believes scaled commercialization is most likely around 2028.
- Mainstream technology efficiency frameworkCdTe approximately 20%, crystalline silicon approximately 25%, perovskites approximately 30%The report summarizes the approximate efficiencies of the three solar-panel technologies as 20%-25%-30%.
- Silicon-perovskite tandem efficiency upliftApproximately 30%The report states that adding perovskites to silicon panels adds limited weight while potentially increasing efficiency by approximately 30%.
- Tandem PV demonstration result30.4% efficiency for a 100cm² demonstration moduleInternal test result undergoing third-party certification; the perovskite sub-cell achieved 21.7% and the underlying Maxeon IBC cell achieved 8.7%.
- Tandem PV fundingApproximately $100MThe company snapshot indicates approximately seven funding rounds since inception, with Series A led by Eclipse.
- FSLR rating and target priceUnderperform, $197/shBernstein maintains an underweight view on First Solar.
- TE rating and target priceMarket-Perform, $9/shBernstein rates T1 Energy Market-Perform.
Impact & implications
If perovskites achieve bankable commercialization around 2028, they could reshape the competitive landscape for solar modules: high-efficiency modules would command a premium in settings constrained by land, grid-interconnection capacity, labor, and rooftop space. For FSLR, perovskites could weaken the relative advantage of the CdTe route; for TE, there is no near-term technology overlap, but its US manufacturing narrative could create partnership opportunities with perovskite developers.
Risks
- Perovskites may experience ion migration, halide segregation, and moisture ingress under light and heat exposure, leading to performance degradation.
- High-efficiency formulations typically contain lead; damaged encapsulation or improper handling could create lead-leakage risks, while lead-free alternatives still lag in efficiency and stability.
- The 20-year warranty target lacks sufficient field-data support, while utility projects typically require validation of 20- to 30-year asset lifetimes.
- Manufacturing uniformity and yield at scale could become the primary reasons for delays to mass production.
- For FSLR, perovskite progress could create a technology-substitution threat; for TE, future partnership execution and policy support remain uncertain.
What to watch
- Whether perovskite companies can provide 20-year warranties and bankable field data in 2027-2028.
- Tandem PV's full-size commercial-module efficiency targets and progress toward third-party certification.
- Which architecture, 2T or 4T, achieves stable mass production faster.
- Progress on FSLR's Oxford PV license, internal perovskite R&D, and CdTe efficiency improvements.
- The level of support that US IRA/45X, FEOC compliance, and solar-manufacturing reshoring policies provide to TE and perovskite manufacturers.